Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000932471-17-002483
Filing Date
2017-02-13
Accepted
2017-02-13 08:22:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 intracellulartherapiesinc.htm SC 13G 47376
  Complete submission text file 0000932471-17-002483.txt   48933
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87380 | Film No.: 17595966
SIC: 2834 Pharmaceutical Preparations